Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin Plus Phentermine in Overweight and Obese Adults
NCT01987427Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Oct 2013
- Primary completion
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of lorcaserin in obesity and Overweight, sponsored by Eisai Co., Ltd. Primary endpoint: Percentage of Participants Reporting at Least One of Nine Adverse Events (AEs) of Main Interests That May Related to Serotonergic Reaction at 12 weeks. Started Oct 2013; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesityOverweight
Beyond the preview
Go deeper on NCT01987427.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01987427.